6.
Capassoni M, Ketabchi S, Cassisa A, Caramelli R, Molinu A, Galluccio F
. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report. J Med Virol. 2021; 93(10):5718-5720.
PMC: 8426669.
DOI: 10.1002/jmv.27175.
View
7.
Matarneh A, Hani Al-Battah A, Farooqui K, Ghamoodi M, Alhatou M
. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect. Clin Case Rep. 2021; 9(9):e04756.
PMC: 8405530.
DOI: 10.1002/ccr3.4756.
View
8.
Ozaka S, Kodera T, Ariki S, Kobayashi T, Murakami K
. Acute pancreatitis soon after COVID-19 vaccination: A case report. Medicine (Baltimore). 2022; 101(2):e28471.
PMC: 8757977.
DOI: 10.1097/MD.0000000000028471.
View
9.
Notarte K, Ver A, Velasco J, Pastrana A, Catahay J, Salvagno G
. Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review. Crit Rev Clin Lab Sci. 2022; 59(6):373-390.
PMC: 8935447.
DOI: 10.1080/10408363.2022.2038539.
View
10.
Lu H, Stratton C, Tang Y
. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020; 92(4):401-402.
PMC: 7166628.
DOI: 10.1002/jmv.25678.
View
11.
Notarte K, Guerrero-Arguero I, Velasco J, Ver A, de Oliveira M, Catahay J
. Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review. J Med Virol. 2022; 94(7):2939-2961.
PMC: 9088566.
DOI: 10.1002/jmv.27688.
View
12.
Bucci E, Berkhof J, Gillibert A, Gopalakrishna G, Calogero R, Bouter L
. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial. Lancet. 2021; 397(10288):1881-1883.
PMC: 9751705.
DOI: 10.1016/S0140-6736(21)00899-0.
View
13.
Logunov D, Dolzhikova I, Shcheblyakov D, Tukhvatulin A, Zubkova O, Dzharullaeva A
. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275):671-681.
PMC: 7852454.
DOI: 10.1016/S0140-6736(21)00234-8.
View
14.
Etemadifar M, Akhavan Sigari A, Sedaghat N, Salari M, Nouri H
. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin Immunother. 2021; 17(10):3481-3483.
PMC: 8437516.
DOI: 10.1080/21645515.2021.1928463.
View
15.
Sayehmiri K, Abangah G, Kalvandi G, Tavan H, Aazami S
. Prevalence of peptic ulcer in Iran: Systematic review and meta-analysis methods. J Res Med Sci. 2018; 23:8.
PMC: 5813297.
DOI: 10.4103/jrms.JRMS_1035_16.
View
16.
Baimukhamedov C, Makhmudov S, Botabekova A
. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection. Int J Rheum Dis. 2021; 24(11):1440-1441.
PMC: 8652505.
DOI: 10.1111/1756-185X.14220.
View
17.
Bogdanos D, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D
. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol. 2005; 12(3):217-24.
PMC: 2275415.
DOI: 10.1080/17402520500285247.
View
18.
Martin T, Wan D, Hajifathalian K, Tewani S, Shah S, Mehta A
. Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study. Am J Gastroenterol. 2020; 115(10):1609-1616.
PMC: 7446989.
DOI: 10.14309/ajg.0000000000000805.
View
19.
Salehi A, Salehi H, Hasanzarrini M
. Esophagitis Dissecans Superficialis after COVID-19; A Case Report. Middle East J Dig Dis. 2023; 14(3):346-348.
PMC: 9489431.
DOI: 10.34172/mejdd.2022.293.
View
20.
Baimukhamedov C
. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection. Int J Rheum Dis. 2021; 24(9):1218-1220.
PMC: 8441889.
DOI: 10.1111/1756-185X.14202.
View